top of page
FBX2.png

The latest food and beverage industry news and trend analysis

Sirio Europe has announced the launch of LifeChews, a patented, plant-based, chewable "jelly tablet" designed to deliver high payloads of active ingredients. The new format addresses long-standing industry challenges regarding the stability and bioavailability of oil-soluble actives, providing nutraceutical brands with a versatile vehicle for trending health categories.


The launch comes as market data from ITC indicates a significant shift in consumer priorities, with 43% of purchasers seeking greater efficacy and 45% prioritizing pleasant taste when selecting supplement formats.



Advanced Bioavailability and Dispersion Technology

LifeChews utilise a patented technology that ensures the uniform dispersion of 5 μm oil droplets. This particle size is comparable to lipid structures found in human milk, which Sirio credits for the format's optimised absorption.


Clinical studies cited by the company demonstrate significant performance metrics:


  • Enhanced Absorption: LifeChews achieved a 161% higher blood plasma DHA concentration compared to control groups.


  • Improved Bioavailability: The format represents a 198% improvement in overall bioavailability for targeted actives.


  • Stability: Digestion studies confirmed an even distribution of DHA during simulated gastric and intestinal conditions, indicating high stability during the digestive process.



Versatile Application Across Health Categories

The jelly tablet format is specifically engineered for lipid-based nutrients that have traditionally been difficult to formulate in chewable formats due to oxidation, poor dispersibility, and unpleasant aftertastes.


LifeChews are suitable for a wide range of ingredients, including:


  • Omega-3 oils

  • Fat-soluble vitamins

  • Coenzyme Q10

  • Carotenoids (such as lutein and astaxanthin)


Sirio has already developed four initial concepts utilising the format, targeting brain health, heart health, immunity, and longevity—sectors that currently dominate consumer interest.



Strategic Market Positioning

By combining high-nutrient payloads with a plant-based, chewable delivery system, Sirio aims to help its partner brands differentiate themselves in a crowded marketplace.


"LifeChews are a gamechanger in how consumers experience supplements," said Sara Lesina, General Manager at Sirio Europe. She noted that the combination of clinical validation and high payload capacity allows brands to deliver real added value in high-growth categories.


The introduction of LifeChews provides a functional solution for manufacturers looking to move away from traditional softgels or standard gummies toward more effective, scientifically backed delivery systems.

Article
Article
Nov - Food Bev - Website Banner - TIJ vs TTO 300x250.gif

Sirio Europe Debuts LifeChews to Solve Lipid Formulation Challenges

News
News
March 16, 2026
Sirio Europe Debuts LifeChews to Solve Lipid Formulation Challenges
Asset 8.png
Technology

Cornelius Launches ACSD Automated Beverage System for QSR

Asset 8.png
Health & Nutrition

Munchkin Enters Consumables Market with Infant Formula Launch and Target Exclusivity

Asset 8.png
Ingredients

Vivici Unlocks 'Pink Gold' with US Launch of Precision Fermentation-Derived Lactoferrin

Asset 8.png
Ingredients

Döhler Begins Commercial Production of Superbrewed Food's Postbiotic Protein Following Strategic Investment

Related news
You’re reading a free preview of The Newsroom 📰

✅ Get full access to The Newsroom — your personalised F&B feed with curated insights, company updates, and announcements. + access to the full app collection from FNBX

bottom of page